These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3138539)

  • 21. Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B.
    Levine PH
    N Engl J Med; 1974 Dec; 291(26):1381-4. PubMed ID: 4427642
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemophilia replacement therapy in developing countries: complementary approaches to the question of indigenous product manufacture versus importation.
    Gellert GA
    Thromb Haemost; 1996 Feb; 75(2):373-4. PubMed ID: 8815594
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemophilia treatment: its relationship to blood products.
    Aledort LM; Goodnight SH
    Prog Hematol; 1981; 12():125-41. PubMed ID: 6803297
    [No Abstract]   [Full Text] [Related]  

  • 24. Cryoprecipitate revisited.
    Aledort LM
    Transfusion; 1988; 28(4):295-6. PubMed ID: 3133841
    [No Abstract]   [Full Text] [Related]  

  • 25. Normal T-cell subset ratios in patients with severe haemophilia A treated with cryoprecipitate.
    Rasi VP; Koistinen JL; Lohman CM; Silvennoinen OJ
    Lancet; 1984 Feb; 1(8374):461. PubMed ID: 6142197
    [No Abstract]   [Full Text] [Related]  

  • 26. The safe blood components for a hemophilia patient: a case report.
    Chuansumrit A; Pandhawong S; Tardtong P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():198-200. PubMed ID: 7886573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant factor VIII in hemophilia.
    Cohen A; Butler R
    N Engl J Med; 1991 May; 324(21):1515-6. PubMed ID: 1902552
    [No Abstract]   [Full Text] [Related]  

  • 28. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

  • 29. [Statistic considerations in the treatment of patients with coagulation disorders: 2 methods of approach].
    Moro GF; Campolongo F
    Riv Ital Stomatol; 1983; 52(7-8):589-92. PubMed ID: 6236541
    [No Abstract]   [Full Text] [Related]  

  • 30. Impaired cell-mediated immunity in patients with classic hemophilia.
    Lederman MM; Ratnoff OD; Scillian JJ; Jones PK; Schacter B
    N Engl J Med; 1983 Jan; 308(2):79-83. PubMed ID: 6216408
    [No Abstract]   [Full Text] [Related]  

  • 31. Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group.
    Walker I; Poon MC
    Lancet; 1992 Jan; 339(8784):61-2. PubMed ID: 1345984
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preparation of the antihemophilic cryoprotein from the acidified plasma. I].
    Vlcková M; Vopatová M
    Vnitr Lek; 1972 Aug; 18(8):795-800. PubMed ID: 5054177
    [No Abstract]   [Full Text] [Related]  

  • 33. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 34. Dr Judith Graham Pool and the development of cryoprecipitate.
    Swenson E; Hollenhorst MA
    Transfusion; 2021 Jun; 61(6):1676-1677. PubMed ID: 33894065
    [No Abstract]   [Full Text] [Related]  

  • 35. Intraarticular bleeding in children with hemophilia: the prevention of arthropathy.
    Gregosiewicz A; Wośko I; Kandzierski G
    J Pediatr Orthop; 1989; 9(2):182-5. PubMed ID: 2494223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A regional redistribution programme for the optimal management of clotting factor concentrates prescribed by haemophilia treatment centres.
    Crymble S; Anderson M; Travas A; Floros G; Teitel J
    Transfus Med; 2013 Oct; 23(5):370-2. PubMed ID: 23763626
    [No Abstract]   [Full Text] [Related]  

  • 37. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 38. [Principles of modern therapy for hemophilia A and B in childhood].
    Ströder J; Ambs E
    Dtsch Med Wochenschr; 1968 Mar; 93(12):539-41. PubMed ID: 5639667
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemostatic treatment with cryoprecipitate and antifibrinolytics in a hemophilic patient subjected to tonsillectomy].
    Mancini AF; Rosito P; Paolucci G; Zanini A
    Minerva Pediatr; 1971 May; 23(19):868-75. PubMed ID: 5560087
    [No Abstract]   [Full Text] [Related]  

  • 40. HTLV-III, haemophilia and blood transfusion.
    Mitchell VE; Martin C; Flower AJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6489):213. PubMed ID: 2990635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.